Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.10339
Abstract: Key Points Question What is the recommended dose of difelikefalin, a κ-opioid receptor agonist, in Japanese patients with moderate to severe pruritus receiving hemodialysis? Findings In this phase 2 randomized clinical trial of 247 patients,… read more here.
Keywords: receiving hemodialysis; severe pruritus; safety; moderate severe ... See more keywords